Lack of interleukin-33 and its receptor does not prevent calcipotriol-induced atopic dermatitis-like inflammation in mice.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 04 2020
15 04 2020
Historique:
received:
28
01
2020
accepted:
20
03
2020
entrez:
17
4
2020
pubmed:
17
4
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Current studies addressing the influence of interleukin-33 or its receptor (IL-33R/ST2) on development of atopic dermatitis-like inflammation in mice have reported conflicting results. We compared the response in single- and double-deficient IL-33
Identifiants
pubmed: 32296080
doi: 10.1038/s41598-020-63410-z
pii: 10.1038/s41598-020-63410-z
pmc: PMC7160114
doi:
Substances chimiques
Il1rl1 protein, mouse
0
Il33 protein, mouse
0
Interleukin-1 Receptor-Like 1 Protein
0
Interleukin-33
0
calcipotriene
143NQ3779B
Calcitriol
FXC9231JVH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6451Références
Bieber, T. Atopic dermatitis. The New England journal of medicine 358, 1483–1494 (2008).
doi: 10.1056/NEJMra074081
Brunner, P. M., Leung, D. Y. M. & Guttman-Yassky, E. Immunologic, microbial, and epithelial interactions in atopic dermatitis. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 120, 34–41 (2018).
doi: 10.1016/j.anai.2017.09.055
Gittler, J. K. et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. The Journal of allergy and clinical immunology 130, 1344–1354 (2012).
doi: 10.1016/j.jaci.2012.07.012
Moosbrugger-Martinz, V., Schmuth, M. & Dubrac, S. A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903. Methods in molecular biology (Clifton, N.J.) 1559, 91–106 (2017).
doi: 10.1007/978-1-4939-6786-5_8
Salimi, M. et al. A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis. Journal of Experimental Medicine 210, 2939–2950 (2013).
doi: 10.1084/jem.20130351
Kim, B. S. et al. TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation. Science Translational Medicine 5, 170ra16–170ra16 (2013).
doi: 10.1126/scitranslmed.3005374
Sundnes, O. et al. Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences. J. Invest. Dermatol. 135, 1771–1780 (2015).
doi: 10.1038/jid.2015.85
Pichery, M. et al. Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain. The Journal of Immunology 188, 3488–3495 (2012).
doi: 10.4049/jimmunol.1101977
Schmitz, J. et al. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity 23, 479–490 (2005).
doi: 10.1016/j.immuni.2005.09.015
Savinko, T. et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J. Invest. Dermatol. 132, 1392–1400 (2012).
doi: 10.1038/jid.2011.446
Hueber, A. J. et al. IL-33 induces skin inflammation with mast cell and neutrophil activation. European journal of immunology 41, 2229–2237 (2011).
doi: 10.1002/eji.201041360
Shimizu, M. et al. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Human molecular genetics 14, 2919–2927 (2005).
doi: 10.1093/hmg/ddi323
Du, H.-Y. et al. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway. J. Interferon Cytokine Res. 36, 552–562 (2016).
doi: 10.1089/jir.2015.0159
Imai, Y. et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc. Natl. Acad. Sci. U.S.A 110, 13921–13926 (2013).
doi: 10.1073/pnas.1307321110
Islam, S. A. & Luster, A. D. T cell homing to epithelial barriers in allergic disease. Nat. Med 18, 705–715 (2012).
doi: 10.1038/nm.2760
Li, M. et al. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. PNAS 103, 11736–11741 (2006).
doi: 10.1073/pnas.0604575103
Li, C. et al. Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells. Cell Death Dis 8, e2735–e2735 (2017).
doi: 10.1038/cddis.2017.90
Chen, Y.-L. et al. Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Science Translational Medicine 11, eaax2945 (2019).
doi: 10.1126/scitranslmed.aax2945
Idrus, Al, A. AnaptysBio’s IL-33 antibody stumbles in midphase eczema trial. fiercebiotech.com Available at, https://www.fiercebiotech.com/biotech/anaptysbio-s-il-33-antibody-stumbles-midphase-eczema-trial ., (Accessed: 3rd March 2020).
Mekada, K. et al. Genetic differences among C57BL/6 substrains. Experimental animals 58, 141–149 (2009).
doi: 10.1538/expanim.58.141
Simon, M. M. et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol. 14, 1–22 (2013).
doi: 10.1186/gb-2013-14-7-r82
Silver, L. M. Mouse Genetics. (Taylor & Francis US, 1995).
Martin, P. et al. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency. Arthritis research & therapy 15, R13 (2013).
doi: 10.1186/ar4143
Faul, F., Erdfelder, E., Lang, A.-G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39, 175–191 (2007).
doi: 10.3758/BF03193146